Physician profile
Ryan Casey
NPI 1144908252
$1,102.39
in general payments reported to CMS, 2019-2025
19 companies · $751 in 2025
The $751 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.45 · 2024: $332 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $209.30 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $158.90 | 2025 | Repatha |
| Abbvie INC. | $130.12 | 2024-2025 | |
| Lilly USA, LLC | $93.73 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $70.94 | 2024-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $65.65 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $60.09 | 2024-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.26 | 2024-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $47.21 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $36.20 | 2024 | Voquezna |
| Dexcom, INC. | $27.73 | 2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $25.17 | 2025 | Orgovyx |
| Sanofi Pasteur INC. | $21.10 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.81 | 2025 | Xifaxan |
| Ibsa Pharma INC. | $19.45 | 2023 | Tirosint, Licart |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $19.23 | 2025 | Korlym |
| Antares Pharma, INC. | $18.32 | 2024 | Xyosted |
| E.R. Squibb & Sons, L.L.C. | $17.60 | 2025 | Eliquis |
| Valencia Technologies Corporation | $14.58 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.